Dr. Reddy's Looks To Acquire U.S. Generics Company Following $115 Mil. IPO
Dr. Reddy's Laboratories plans to expand its presence in the U.S. generics market through acquisitions following its April 11 initial public offering.
Dr. Reddy's Laboratories plans to expand its presence in the U.S. generics market through acquisitions following its April 11 initial public offering.